25-OH Vitamin D Deficiency in Inflammatory States is not a Reflection of Low Vitamin D Binding Protein Levels

Authors

  • Jonathan D. Jones Department of Medicine, Section of Rheumatology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
  • William F. Rigby Department of Medicine, Section of Rheumatology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA

DOI:

https://doi.org/10.12970/2310-9874.2014.02.02.5

Keywords:

 Vitamin D, Vitamin D binding protein, Inflammation, Autoimmune disease, Rheumatoid arthritis.

Abstract

Background: Vitamin D binding protein (DBP) levels can profoundly influence 25-OH vitamin D levels. An increased incidence of vitamin D deficiency exists in autoimmune diseases. We hypothesized that low 25-OH vitamin D levels were a reflection of low DBP levels due to the influence of inflammation on hepatic synthesis.

Methods: Serum and plasma samples from patients with inflammatory autoimmune diseases were evaluated for levels of DBP and 25-OH vitamin D. Inflammatory markers high-sensitivity C-reactive protein (hsCRP) and erythrocyte sedimentation rate (ESR) were obtained from the clinical lab. Statistical significance was determined by Spearman correlation.

Results: We identified a broad range of DBP levels (74 to 614 μg/ml) across patients. However, neither DBP nor 25-OH vitamin D levels had any relationship to absolute values of hsCRP or ESR. In addition, in patients with serial samples wherein the inflammatory markers decreased by 25% or more, there was no consistent change in DBP.

Conclusions: DBP levels are unaffected by inflammation, therefore, vitamin D deficiency in autoimmune inflammatory diseases is not simply due to decreased levels of DBP.

References

Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007; 56: 2143-9. http://dx.doi.org/10.1002/art.22722

Rossini M, MaddaliBongi S, La Montagna G, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010; 12: R216.

Ben-Zvi I, Aranow C, Mackay M, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.PLoS One 2010; 5: e9193. http://dx.doi.org/10.1371/journal.pone.0009193

Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-7. http://dx.doi.org/10.1016/j.autrev.2005.05.009

Cutolo M, Otsa K, Laas K, et al. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006; 24: 702-4.

Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol 2007; 103: 631-4. http://dx.doi.org/10.1016/j.jsbmb.2006.12.066

Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 1975; 72: 2076-80. http://dx.doi.org/10.1073/pnas.72.6.2076

White P, Cooke N.The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000; 11: 320-7. http://dx.doi.org/10.1016/S1043-2760(00)00317-9

Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999; 103: 239-51. http://dx.doi.org/10.1172/JCI5244

Bikle DD, Gee E. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 1989; 124: 649-54. http://dx.doi.org/10.1210/endo-124-2-649

Bhan I, Powe CE, Berg AH, et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int 2012; 82: 84-9. http://dx.doi.org/10.1038/ki.2012.19

Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013; 369: 1991-2000. http://dx.doi.org/10.1056/NEJMoa1306357

Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, Labadarios D. Blood vitamin concentrations during the acute-phase response. Crit Care Med 1992; 20: 934-41. http://dx.doi.org/10.1097/00003246-199207000-00007

McLeod JF, Cooke NE. The vitamin D-binding protein, alpha-fetoprotein, albuminmultigene family: detection of transcripts in multiple tissues. J Biol Chem 1989; 264: 21760-9.

Blanton D, Han Z, Bierschenk L, et al. Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes 2011; 60: 2566-70. http://dx.doi.org/10.2337/db11-0576

Reid D, Toole BJ, Knox S, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011; 93: 1006-11. http://dx.doi.org/10.3945/ajcn.110.008490

Downloads

Published

2014-08-05

Issue

Section

Articles